日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence

前列腺癌中遗传祖先一致的 RNA 剪接涉及致癌基因并与复发相关

Muthana Al Abo, Wen-Chi Foo, Lauren E Howard, Shannon McGue, Bonnie Lacroix, Julie Kephart, Angela Clayton, Blair Thornburg, Monika Anand, Michael B Rothberg, Shannon J McCall, Jiaoti Huang, Thomas A Esther, Judd W Moul, Michael N Ferrandino, Thomas J Polascik, Cary N Robertson, Brant A Inman, Andre

Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy

分子分型预测临床局限于器官内的膀胱癌患者行根治性膀胱切除术后的病理分期升级和生存结局

de Jong, Joep J; Proudfoot, James A; Daneshmand, Siamak; Svatek, Robert S; Narayan, Vikram; Davicioni, Elai; Joshi, Shreyas; Dahmen, Aaron; Li, Roger; Inman, Brant A; Shah, Paras; Chaplin, Iftach; Wright, Jonathan; Gibb, Ewan A; Lotan, Yair

A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy

基于管腔非编码RNA的基因组分类器证实,接受根治性膀胱切除术治疗的临床局限性膀胱癌患者预后良好。

de Jong, Joep J; Proudfoot, James A; Daneshmand, Siamak; Svatek, Robert S; Narayan, Vikram; Gibb, Ewan A; Davicioni, Elai; Joshi, Shreyas; Dahmen, Aaron; Li, Roger; Inman, Brant A; Shah, Paras; Chaplin, Iftach; Wright, Jonathan; Lotan, Yair

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

膀胱内灌注纳多法拉根·菲拉德诺维克治疗卡介苗无反应性非肌层浸润性膀胱癌患者的疗效:一项3期试验的5年随访结果

Narayan, Vikram M; Boorjian, Stephen A; Alemozaffar, Mehrdad; Konety, Badrinath R; Shore, Neal D; Gomella, Leonard G; Kamat, Ashish M; Bivalacqua, Trinity J; Montgomery, Jeffrey S; Lerner, Seth P; Busby, Joseph E; Poch, Michael; Crispen, Paul L; Steinberg, Gary D; Schuckman, Anne K; Downs, Tracy M; Mashni, Joseph Jr; Lane, Brian R; Guzzo, Thomas J; Bratslavsky, Gennady; Karsh, Lawrence I; Woods, Michael E; Brown, Gordon; Canter, Daniel; Luchey, Adam; Lotan, Yair; Inman, Brant A; Williams, Michael B; Cookson, Michael S; Chang, Sam S; Sankin, Alexander I; O'Donnell, Michael A; Sawutz, David; Philipson, Richard; Parker, Nigel R; Yla-Herttuala, Seppo; Rehm, Dorte; Jakobsen, Jørn S; Juul, Kristian; Dinney, Colin P N

Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics

尿路上皮原位癌的多组学分析揭示了 CIS 特异性基因特征和免疫特征

Meenakshi Anurag, Trine Strandgaard, Sung Han Kim, Yongchao Dou, Eva Comperat, Hikmat Al-Ahmadie, Brant A Inman, Ann Taber, Iver Nordentoft, Jørgen Bjerggaard Jensen, Lars Dyrskjøt, Seth P Lerner

2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma

2024年CUA-KCRNC专家报告:非透明细胞肾细胞癌的治疗

Graham, Jeffrey; Ahmad, Ardalan E; Basappa, Naveen S; Bernhard, Jean-Christophe; Bhindi, Bimal; Bossé, Dominick; Breau, Rodney H; Canil, Christina M; Castonguay, Vincent; Finelli, Antonio; Heng, Daniel Y C; Inman, Brant A; Kollmannsberger, Christian; Lalani, Aly-Khan A; Lavallée, Luke T; Msaouel, Pavlos; Prendeville, Susan; Soleimani, Maryam; Tanguay, Simon; Wood, Lori; Richard, Patrick O

Whole exome sequencing analysis of canine urothelial carcinomas without BRAF V595E mutation: Short in-frame deletions in BRAF and MAP2K1 suggest alternative mechanisms for MAPK pathway disruption

无 BRAF V595E 突变的犬尿路上皮癌的全外显子组测序分析:BRAF 和 MAP2K1 中的短框内缺失提示 MAPK 通路中断的替代机制

Rachael Thomas, Claire A Wiley, Emma L Droste, James Robertson, Brant A Inman, Matthew Breen

Erratum to "Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy" [Eur Urol 2022;81(5):446-55]

对“原发性前列腺癌中预先存在的去势抵抗性前列腺癌样细胞促进对激素疗法的耐药性”的勘误 [Eur Urol 2022;81(5):446-55]

Cheng, Qing; Butler, William; Zhou, Yinglu; Zhang, Hong; Tang, Lu; Perkinson, Kathryn; Chen, Xufeng; Jiang, Xiaoyin Sara; McCall, Shannon J; Inman, Brant A; Huang, Jiaoti

Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy

原发性前列腺癌中预先存在的去势抵抗性前列腺癌样细胞会促进对激素治疗的抵抗

Qing Cheng, William Butler, Yinglu Zhou, Hong Zhang, Lu Tang, Kathryn Perkinson, Xufeng Chen, Xiaoyin Sara Jiang, Shannon J McCall, Brant A Inman, Jiaoti Huang

Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry

对源自西非裔患者的去势抵抗性前列腺癌异种移植瘤进行表征

Brendon M Patierno ,Wen-Chi Foo ,Tyler Allen ,Jason A Somarelli ,Kathryn E Ware ,Santosh Gupta ,Sandra Wise ,John P Wise Sr ,Xiaodi Qin ,Dadong Zhang ,Lingfan Xu ,Yanjing Li ,Xufeng Chen ,Brant A Inman ,Shannon J McCall ,Jiaoti Huang ,Rick A Kittles ,Kouros Owzar ,Simon Gregory ,Andrew J Armstrong ,Daniel J George ,Steven R Patierno ,David S Hsu # ,Jennifer A Freedman #